Scott Stryker

1.6k total citations
34 papers, 915 citations indexed

About

Scott Stryker is a scholar working on Hematology, Rheumatology and Oncology. According to data from OpenAlex, Scott Stryker has authored 34 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 12 papers in Rheumatology and 10 papers in Oncology. Recurrent topics in Scott Stryker's work include Autoimmune and Inflammatory Disorders Research (9 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Neutropenia and Cancer Infections (5 papers). Scott Stryker is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (9 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Neutropenia and Cancer Infections (5 papers). Scott Stryker collaborates with scholars based in United States, United Kingdom and Sweden. Scott Stryker's co-authors include Shuling Li, John Acquavella, Karynsa Cetin, Thomas J. Arneson, Anne Blaes, Yi Peng, Eric D. Weinhandl, Victoria M. Chia, Joseph J. Pinzone and John Knight and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Bone and Joint Surgery.

In The Last Decade

Scott Stryker

32 papers receiving 877 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott Stryker United States	14	285	216	169	165	155	34	915
Jennifer Davis Canada	15	139 0.5×	173 0.8×	166 1.0×	124 0.8×	119 0.8×	29	698
Haruhito Sugiyama Japan	21	403 1.4×	230 1.1×	113 0.7×	148 0.9×	236 1.5×	136	1.5k
Matthieu Picard Canada	19	159 0.6×	103 0.5×	54 0.3×	208 1.3×	190 1.2×	36	1.3k
Stephen W. Olson United States	16	211 0.7×	74 0.3×	113 0.7×	79 0.5×	149 1.0×	34	1.0k
Fumihiko Nakamura Japan	16	111 0.4×	186 0.9×	238 1.4×	99 0.6×	111 0.7×	114	1.1k
T. Ben Abdallah Tunisia	16	125 0.4×	78 0.4×	67 0.4×	240 1.5×	192 1.2×	198	1.0k
Hussain Alizadeh Hungary	18	117 0.4×	238 1.1×	113 0.7×	297 1.8×	78 0.5×	70	897
Beth Wallace United States	14	108 0.4×	105 0.5×	53 0.3×	95 0.6×	78 0.5×	48	695
Theodore X. O'Connell United States	19	296 1.0×	386 1.8×	59 0.3×	471 2.9×	86 0.6×	43	1.1k
Iván Guerra Spain	20	174 0.6×	144 0.7×	36 0.2×	364 2.2×	192 1.2×	73	1.0k

Countries citing papers authored by Scott Stryker

Since Specialization

Citations

This map shows the geographic impact of Scott Stryker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Stryker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Stryker more than expected).

Fields of papers citing papers by Scott Stryker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Stryker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Stryker. The network helps show where Scott Stryker may publish in the future.

Co-authorship network of co-authors of Scott Stryker

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Stryker. A scholar is included among the top collaborators of Scott Stryker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Stryker. Scott Stryker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pappas, Dimitrios A., Jacqueline O’Brien, Lin Guo, et al.. (2023). Treatment patterns and clinical outcomes in patients with rheumatoid arthritis initiating etanercept, adalimumab, or Janus kinase inhibitor as first-line therapy: results from the real-world CorEvitas RA Registry. Arthritis Research & Therapy. 25(1). 166–166. 7 indexed citations

Mease, Philip J., Jacqueline O’Brien, Gregory Kricorian, et al.. (2023). Real‐World Evidence Assessing Psoriatic Arthritis by Disease Domain: An Evaluation of the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry. ACR Open Rheumatology. 5(8). 388–398. 3 indexed citations

Correll, C., Scott Stryker, David H. Collier, et al.. (2023). Occurrence of adverse events and change in disease activity after initiation of etanercept in paediatric patients with juvenile psoriatic arthritis in the CARRA Registry. RMD Open. 9(2). e002943–e002943. 1 indexed citations

Mease, Philip J., Scott Stryker, Mei Liu, et al.. (2021). Treatment patterns in rheumatoid arthritis patients newly initiated on biologic and conventional synthetic disease-modifying antirheumatic drug therapy and enrolled in a North American clinical registry. Arthritis Research & Therapy. 23(1). 236–236. 11 indexed citations

Nowell, W. Benjamin, Kelly Gavigan, Hong Zhao, et al.. (2021). Patient-Reported Nausea and Fatigue Related to Methotrexate: A Prospective, Self-Controlled Study in the ArthritisPower® Registry. Rheumatology and Therapy. 9(1). 207–221. 17 indexed citations

Pappas, Dimitrios A., Ying Shan, Greg Kricorian, et al.. (2020). Maintenance of Sustained Low Disease Activity or Remission in Patients With Rheumatoid Arthritis Treated With Etanercept Monotherapy: Results from the Corrona Registry. ACR Open Rheumatology. 2(10). 588–594. 4 indexed citations

Pappas, Dimitrios A., Heather J. Litman, Greg Kricorian, et al.. (2020). Persistence on biologic DMARD monotherapy after achieving rheumatoid arthritis disease control on combination therapy: retrospective analysis of corrona registry data. Rheumatology International. 41(2). 381–390. 5 indexed citations

Christiansen, Christian Fynbo, Shahram Bahmanyar, Waleed Ghanima, et al.. (2019). Chronic immune thrombocytopenia in Denmark, Sweden and Norway: The Nordic Country Patient Registry for Romiplostim. EClinicalMedicine. 14. 80–87. 20 indexed citations

Lyman, Gary H., Jacob Garcia, Scott Stryker, et al.. (2017). The effectiveness and safety of same-day versus next-day administration of long-acting granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced neutropenia: a systematic review. Supportive Care in Cancer. 25(8). 2619–2629. 34 indexed citations

10.

Langeberg, Wendy J., W. Marieke Schoonen, Melissa Eisen, Laurence Gamelin, & Scott Stryker. (2016). Thromboembolism in patients with immune thrombocytopenia (ITP): a meta-analysis of observational studies. International Journal of Hematology. 103(6). 655–664. 34 indexed citations

11.

Amelio, Justyna, Rohini K. Hernandez, Patrik Sobocki, et al.. (2016). Population-based study of giant cell tumor of bone in Sweden (1983–2011). Cancer Epidemiology. 42. 82–89. 37 indexed citations

12.

Klippel, Zandra, et al.. (2016). Evaluating the appropriateness of granulocyte colony-stimulating factor (G-CSF) use in patients (pts) receiving myelosuppressive chemotherapy by febrile neutropenia (FN) risk level.. Journal of Clinical Oncology. 34(15_suppl). e21691–e21691.

13.

Hernandez, Rohini K., Karynsa Cetin, Melissa Pirolli, et al.. (2015). Estimating high-risk castration resistant prostate cancer (CRPC) using electronic health records.. PubMed. 22(4). 7858–64. 4 indexed citations

14.

Liede, Alexander, Bruce Allen Bach, Scott Stryker, et al.. (2014). Regional Variation and Challenges in Estimating the Incidence of Giant Cell Tumor of Bone. Journal of Bone and Joint Surgery. 96(23). 1999–2007. 33 indexed citations

15.

Cetin, Karynsa, Shuling Li, Anne Blaes, et al.. (2013). Prevalence of Patients With Nonmetastatic Prostate Cancer on Androgen Deprivation Therapy in the United States. Urology. 81(6). 1184–1189. 7 indexed citations

16.

Arneson, Thomas J., Shuling Li, Yi Peng, et al.. (2012). Estimated number of prevalent cases of metastatic bone disease in the US adult population. Clinical Epidemiology. 4. 87–87. 187 indexed citations

17.

Xue, Fei, et al.. (2011). Renal impairment, hemoglobinuria, and hemoglobinemia among patients with idiopathic thrombocytopenic purpura. American Journal of Hematology. 86(9). 738–742. 1 indexed citations

18.

McCroskery, Peter, Carol A. Wallace, Daniel J. Lovell, et al.. (2010). Summary of worldwide pediatric malignancies reported after exposure to etanercept. Pediatric Rheumatology. 8(1). 18–18. 31 indexed citations

19.

Duffy, Ciarán M., et al.. (2002). Tendon or joint disorders in children after treatment with fluoroquinolones or azithromycin. The Pediatric Infectious Disease Journal. 21(6). 525–529. 67 indexed citations

20.

Morgan, Wayne J., Charles A. Johnson, Andrew A. Colin, et al.. (1999). Epidemiologic study of cystic fibrosis: Design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada. Pediatric Pulmonology. 28(4). 231–241. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact